TecTraum Inc. news

TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced complete enrollment status for a clinical trial that began in fall of 2019 using its flagship technology, pro2cool.

The pro2cool system is a novel, noninvasive hypothermic therapy device designed to reduce the severity of concussion symptoms and allow patients to return to their pre-injury baseline sooner. The device provides localized cooling for the head and neck to lo

TecTraum Inc., dedicated to providing the world’s first  point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool, as a Breakthrough Device. The pro2cool System is a novel, non-invasive hypothermic therapy device designed to reduce the severity of concussion symptoms and allow patients to return to their pre-injury baseline sooner. The device provides localized cooling for the head and